All National Institutes of Health articles
-
NewsTrial of rectal microbicide for HIV prevention begins in US
A clinical trial has launched to examine the safety and acceptability of a novel rectal HIV microbicide douche containing the antiretroviral drug tenofovir.
-
NewsEmergency department screening more than doubles detection of syphilis cases
Providing optional syphilis tests to most people seeking care at a large emergency department led to a dramatic increase in syphilis screening and diagnosis, according to a study of nearly 300,000 emergency department encounters in Chicago.
-
NewsLong Covid continues to evade diagnosis
A national cohort study of adult US participants with and without prior SARS-CoV-2 infection found that there are no objective tests to accurately diagnose post-acute sequelae of SARS-CoV-2 infection (PASC), also known as Long Covid.
-
NewsResearchers receive 9.5 million grant to study relationship between polyphenol intake, Alzheimer’s and the brain-gut-microbiome system
UCLA Health researchers, in collaboration with researchers from the Republic of Ireland and Northern Ireland, have received a $9.5 million award to study the effects of polyphenols on cognitive health and the brain-gut microbiome system.
-
NewsNew findings may fix the replicability crisis in microbiome research
Scientists report that daily fluctuations in the gut alter the microbiome so significantly that different bugs populate it in the morning and in the evening.
-
News$1.3 million fund helps to introduce high school students to virus surveillance
The Icahn School of Medicine at Mount Sinai has received more than $1.3 million from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) to expand the New York City Virus Hunters program.
-
NewsHypervirulent bacteria emerging in healthy people
New ’hypervirulent’ strains of the bacterium Klebsiella pneumoniae have emerged in healthy people in community settings, prompting researchers to investigate how the human immune system defends against infection.
-
NewsProbiotic markedly reduces staph colonisation in phase 2 trial
A approach to control Staphylococcus aureus bacterial colonization in people—using a probiotic instead of antibiotics—was found to be safe and highly effective in a Phase 2 clinical trial.
-
NewsExperimental monoclonal antibodies take the fight to Epstein-Barr virus
Researchers have discovered a panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting.
